Skip to the page

Data / Form D filings / Analytica Biosciences Corp.

Analytica Biosciences Corp.: Form D filings

Analytica Biosciences Corp., a biotechnology company in Naples, FL, filed 2 Form D notices with the SEC in 2023. The latest, on September 19, 2023, reports $10,000 sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6305 Naples Boulevard, Suite 1280, Naples, FL, 34109
Phone
(203) 293-6144
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1993415

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 19, 2023Amendment$1,000,000$10,000$990,0001Sep 12, 2023sec.gov
Sep 13, 2023New notice$1,000,000$10,000$990,0001Sep 12, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Asuna Pierpoint GilfoyleExecutive Officer, Director

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Sep 18, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Analytica Biosciences Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.